These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 1978371

  • 1. Efficacy and safety of a putative anxiolytic agent: ipsapirone.
    Borison RL, Albrecht JW, Diamond BI.
    Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371
    [Abstract] [Full Text] [Related]

  • 2. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR, Sramek JJ, Wardle TS, Hesselink JM, Roeschen JK.
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [Abstract] [Full Text] [Related]

  • 3. Buspirone: multicenter efficacy study.
    Wheatley D.
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 5. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.
    Feighner JP, Merideth CH, Hendrickson GA.
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):103-8. PubMed ID: 6130066
    [Abstract] [Full Text] [Related]

  • 6. Early response and 8-week treatment outcome in GAD.
    Rynn M, Khalid-Khan S, Garcia-Espana JF, Etemad B, Rickels K.
    Depress Anxiety; 2006 Dec; 23(8):461-5. PubMed ID: 16845651
    [Abstract] [Full Text] [Related]

  • 7. Buspirone and diazepam in anxiety: a controlled study.
    Rickels K, Weisman K, Norstad N, Singer M, Stoltz D, Brown A, Danton J.
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):81-6. PubMed ID: 6130078
    [Abstract] [Full Text] [Related]

  • 8. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP.
    Encephale; 1995 Dec; 21(6):459-66. PubMed ID: 8674471
    [Abstract] [Full Text] [Related]

  • 10. A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.
    Cutler NR, Hesselink JM, Sramek JJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):447-63. PubMed ID: 7915845
    [Abstract] [Full Text] [Related]

  • 11. A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder.
    Boyer WF, Feighner JP.
    Int Clin Psychopharmacol; 1993 May; 8(3):173-6. PubMed ID: 7903326
    [Abstract] [Full Text] [Related]

  • 12. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS, Young R, Roginsky M.
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [Abstract] [Full Text] [Related]

  • 13. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R, Annable L, Chouinard G, Ogilvie RI.
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [Abstract] [Full Text] [Related]

  • 14. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL, Ishiki D, Avery DH, Wilson LG, Hyde TS.
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [Abstract] [Full Text] [Related]

  • 15. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB, Wilcox CS.
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [Abstract] [Full Text] [Related]

  • 16. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF, Goldstein BJ, Dominguez RA, Steinbook RM.
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [Abstract] [Full Text] [Related]

  • 17. A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states.
    Olajide D, Lader M.
    J Clin Psychopharmacol; 1987 Jun; 7(3):148-52. PubMed ID: 2885344
    [Abstract] [Full Text] [Related]

  • 18. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG.
    J Clin Psychiatry; 1997 Jun; 58 Suppl 11():19-23. PubMed ID: 9363044
    [Abstract] [Full Text] [Related]

  • 19. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE, Naranjo CA, Bremner KE, Peachey JE, Bologa M.
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [Abstract] [Full Text] [Related]

  • 20. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R, Lamontagne Y.
    J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.